Celiac disease surgery: Difference between revisions
Jump to navigation
Jump to search
| (One intermediate revision by one other user not shown) | |||
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
Surgery is not the first | Surgery is not the first line treatment option for patients with celiac disease. Surgery is usually reserved for patients with refractory or pre-malignant complications, such as Enteropathy Associated T-cell [[Lymphoma]] (EATL) and ulcerative jejunitis (UJ). EATL patients presenting with ulcerative lesions, stenotic lesions, and perforation needs surgical intervention. Surgery also serves as a pre-therapy in order to prevent [[perforation]] of the small bowel during chemotherapy in case of EATL<ref name="pmid22271451">{{cite journal |vauthors=Di Sabatino A, Biagi F, Gobbi PG, Corazza GR |title=How I treat enteropathy-associated T-cell lymphoma |journal=Blood |volume=119 |issue=11 |pages=2458–68 |year=2012 |pmid=22271451 |doi=10.1182/blood-2011-10-385559 |url=}}</ref>. After surgery patients receive [[immunotherapy]], [[chemotherapy]] and/or [[stem cell transplantation]].<ref name="pmid26604647">{{cite journal |vauthors=van de Water JM, Nijeboer P, de Baaij LR, Zegers J, Bouma G, Visser OJ, van der Peet DL, Mulder CJ, Meijerink WJ |title=Surgery in (pre)malignant celiac disease |journal=World J. Gastroenterol. |volume=21 |issue=43 |pages=12403–9 |year=2015 |pmid=26604647 |pmc=4649123 |doi=10.3748/wjg.v21.i43.12403 |url=}}</ref><ref name="pmid20333796">{{cite journal |vauthors=Han SL, Cheng J, Zhou HZ, Guo SC, Jia ZR, Wang PF |title=Surgically treated primary malignant tumor of small bowel: a clinical analysis |journal=World J. Gastroenterol. |volume=16 |issue=12 |pages=1527–32 |year=2010 |pmid=20333796 |pmc=2846261 |doi= |url=}}</ref> | ||
==Surgery== | ==Surgery== | ||
===Indications=== | |||
*The small bowel is resected either by a laparoscopic or a laparotomy procedure depending on the location, the setting (elective/acute) and the preference of the surgeon performing the intervention. <ref name="pmid26604647">{{cite journal |vauthors=van de Water JM, Nijeboer P, de Baaij LR, Zegers J, Bouma G, Visser OJ, van der Peet DL, Mulder CJ, Meijerink WJ |title=Surgery in (pre)malignant celiac disease |journal=World J. Gastroenterol. |volume=21 |issue=43 |pages=12403–9 |year=2015 |pmid=26604647 |pmc=4649123 |doi=10.3748/wjg.v21.i43.12403 |url=}}</ref><ref name="pmid20333796">{{cite journal |vauthors=Han SL, Cheng J, Zhou HZ, Guo SC, Jia ZR, Wang PF |title=Surgically treated primary malignant tumor of small bowel: a clinical analysis |journal=World J. Gastroenterol. |volume=16 |issue=12 |pages=1527–32 |year=2010 |pmid=20333796 |pmc=2846261 |doi= |url=}}</ref><ref name="pmid20496543">{{cite journal |vauthors=Coco C, Rizzo G, Manno A, Mattana C, Verbo A |title=Surgical treatment of small bowel neoplasms |journal=Eur Rev Med Pharmacol Sci |volume=14 |issue=4 |pages=327–33 |year=2010 |pmid=20496543 |doi= |url=}}</ref> | * [[Perforation]] | ||
* [[Stenosis]] | |||
* Refractory enteropathy associated T-cell lymphoma (EATL) | |||
* Refractory ulcerative jejunitis (UJ) | |||
===Procedure=== | |||
*The [[small bowel]] is resected either by a [[laparoscopic]] or a [[laparotomy]] procedure depending on the location, the setting (elective/acute) and the preference of the surgeon performing the intervention. <ref name="pmid26604647">{{cite journal |vauthors=van de Water JM, Nijeboer P, de Baaij LR, Zegers J, Bouma G, Visser OJ, van der Peet DL, Mulder CJ, Meijerink WJ |title=Surgery in (pre)malignant celiac disease |journal=World J. Gastroenterol. |volume=21 |issue=43 |pages=12403–9 |year=2015 |pmid=26604647 |pmc=4649123 |doi=10.3748/wjg.v21.i43.12403 |url=}}</ref><ref name="pmid20333796">{{cite journal |vauthors=Han SL, Cheng J, Zhou HZ, Guo SC, Jia ZR, Wang PF |title=Surgically treated primary malignant tumor of small bowel: a clinical analysis |journal=World J. Gastroenterol. |volume=16 |issue=12 |pages=1527–32 |year=2010 |pmid=20333796 |pmc=2846261 |doi= |url=}}</ref><ref name="pmid20496543">{{cite journal |vauthors=Coco C, Rizzo G, Manno A, Mattana C, Verbo A |title=Surgical treatment of small bowel neoplasms |journal=Eur Rev Med Pharmacol Sci |volume=14 |issue=4 |pages=327–33 |year=2010 |pmid=20496543 |doi= |url=}}</ref> | |||
*Mobilization and transection of the bowel are performed and the involved segment resected if possible. | *Mobilization and transection of the bowel are performed and the involved segment resected if possible. | ||
*Resectability is assessed peri-operatively and has three types: | *Resectability is assessed peri-operatively and has three types: | ||
**Radical: Complete resection of the | **Radical: Complete resection of the mass. | ||
**Partial: Some but not all of the | **Partial: Some but not all of the mass is resected. | ||
**Unresectable: Inability to resect any part of the | **Unresectable: Inability to resect any part of the mass. | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Latest revision as of 14:39, 13 September 2017
|
Celiac disease Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Medical Therapy |
|
Case Studies |
|
Celiac disease surgery On the Web |
|
American Roentgen Ray Society Images of Celiac disease surgery |
|
Risk calculators and risk factors for Celiac disease surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ajay Gade MD[2]]
Overview
Surgery is not the first line treatment option for patients with celiac disease. Surgery is usually reserved for patients with refractory or pre-malignant complications, such as Enteropathy Associated T-cell Lymphoma (EATL) and ulcerative jejunitis (UJ). EATL patients presenting with ulcerative lesions, stenotic lesions, and perforation needs surgical intervention. Surgery also serves as a pre-therapy in order to prevent perforation of the small bowel during chemotherapy in case of EATL[1]. After surgery patients receive immunotherapy, chemotherapy and/or stem cell transplantation.[2][3]
Surgery
Indications
- Perforation
- Stenosis
- Refractory enteropathy associated T-cell lymphoma (EATL)
- Refractory ulcerative jejunitis (UJ)
Procedure
- The small bowel is resected either by a laparoscopic or a laparotomy procedure depending on the location, the setting (elective/acute) and the preference of the surgeon performing the intervention. [2][3][4]
- Mobilization and transection of the bowel are performed and the involved segment resected if possible.
- Resectability is assessed peri-operatively and has three types:
- Radical: Complete resection of the mass.
- Partial: Some but not all of the mass is resected.
- Unresectable: Inability to resect any part of the mass.
References
- ↑ Di Sabatino A, Biagi F, Gobbi PG, Corazza GR (2012). "How I treat enteropathy-associated T-cell lymphoma". Blood. 119 (11): 2458–68. doi:10.1182/blood-2011-10-385559. PMID 22271451.
- ↑ 2.0 2.1 van de Water JM, Nijeboer P, de Baaij LR, Zegers J, Bouma G, Visser OJ, van der Peet DL, Mulder CJ, Meijerink WJ (2015). "Surgery in (pre)malignant celiac disease". World J. Gastroenterol. 21 (43): 12403–9. doi:10.3748/wjg.v21.i43.12403. PMC 4649123. PMID 26604647.
- ↑ 3.0 3.1 Han SL, Cheng J, Zhou HZ, Guo SC, Jia ZR, Wang PF (2010). "Surgically treated primary malignant tumor of small bowel: a clinical analysis". World J. Gastroenterol. 16 (12): 1527–32. PMC 2846261. PMID 20333796.
- ↑ Coco C, Rizzo G, Manno A, Mattana C, Verbo A (2010). "Surgical treatment of small bowel neoplasms". Eur Rev Med Pharmacol Sci. 14 (4): 327–33. PMID 20496543.